// App-Quantinova.ai

: VENOUS THROMBOSIS AND BASELINE C-REACTIVE PROTEIN ARE INDEPENDENT PROGNOSTIC MARKERS IN DIFFUSE LARGE B-CELL LYMPHOMA AND IDENTIFY A GROUP OF PATIENTS WITH SIGNIFICANTLY INFERIOR OUTCOMES

Researchers

Presenter

  • Mark Grech

Principal Investigators

  • Daniel Farrugia

  • David-James Camilleri

  • Alex Gatt

Medical Centers

  • Haematology,Sir Anthony Mamo Oncology Centre,Msida,Malta

Locations

  • Malta

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Diffuse large B-cell lymphoma

  • Venous thrombosis

  • B cell lymphomas

  • Lymphomas

Biomarkers

  • C reactive protein

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved